# Discharge Summary Generator - Quick Reference

## üéØ 8 Major Pathology Categories

### 1. ü©∏ Subarachnoid Hemorrhage (SAH)
**Key Extractions**: Ictus date, H&H/WFNS grade, EVD/LD, vasospasm, coiling/clipping
**Critical**: Ictus date (95%+ accuracy required)
**Common Terms**: aSAH, mFisher, TCD, levophed, milrinone

---

### 2. üß† Brain Tumors (Primary)
**Key Extractions**: Resection extent (GTR/STR), pathology, dexamethasone, deficits
**Critical**: Infection detection (abscess, ventriculitis, meningitis)
**Common Terms**: WHO grade, IDH mutation, recurrence, progression

---

### 3. üíß Hydrocephalus
**Key Extractions**: Shunt type (VP/VA/LP), valve type, setting, dysfunction type
**Critical**: Setting changes with dates
**Common Terms**: Proximal/distal catheter, programmable valve, obstructed

---

### 4. üöë Traumatic Brain Injury & Chronic Subdural Hematoma

#### 4A. Acute TBI
**Key Extractions**: GCS, hemorrhage types (SDH/EDH/SAH/IVH/contusion/DAI), mass effect
**Critical**: Decompressive craniectomy, ICP management
**Common Terms**: Blooming, expansion, midline shift, herniation

#### 4B. Chronic Subdural Hematoma (cSDH) ‚≠ê NEW
**Key Extractions**: 
- **Anticoagulation status** (CRITICAL)
- Procedure: twist drill vs burr hole vs craniotomy
- MMA embolization (timing, technique)
- Repeat CT schedule (POD 1, 3-5, 4-6 weeks)
- Reaccumulation, pneumocephalus

**Common Terms**: 
- Twist drill craniostomy, burr hole craniotomy, membranectomy
- JP drain, subdural drain
- MMA embo, liquid embolic, Onyx
- Acute-on-chronic, septations, organized

---

### 5. üíß CSF Leak
**Key Extractions**: Beta-2 transferrin, ACTH/cortisol, lumbar drain, endocrine insufficiency
**Critical**: Stress dose steroids
**Common Terms**: High-flow leak, pituitary dysfunction, prednisone

---

### 6. ü¶¥ Spine
**Key Extractions**: Motor groups (C5-S1) with MRC grading (0-5), symptoms, levels
**Critical**: Pre-op vs post-op motor comparison
**Common Terms**: 
- **C5**: Deltoid (shoulder abduction)
- **C6**: Biceps (elbow flexion), wrist extension
- **C7**: Triceps (elbow extension), wrist flexion
- **C8**: Finger flexion
- **T1**: Finger abduction
- **L2**: Hip flexion
- **L3**: Knee extension
- **L4**: Ankle dorsiflexion
- **L5**: Great toe extension
- **S1**: Ankle plantarflexion

**Symptoms**: Radiculopathy, myelopathy, claudication, cauda equina

---

### 7. ‚ö° Seizures & Status Epilepticus ‚≠ê NEW
**Key Extractions**:
- **Seizure type**: Focal, generalized, GTC, status epilepticus, subclinical
- **EEG**: Continuous (cEEG) vs routine, findings
- **AEDs**: Keppra (LEV), lacosamide (LCM), phenytoin (PHT), phenobarbital
- **Dosing**: Loading doses, maintenance, levels
- **Management**: First/second/third-line protocols

**Critical Terms**:
- **Keppra**: 1000-1500 mg load, 500-1500 mg BID maintenance
- **Lacosamide**: 200-400 mg load, 100-200 mg BID
- **Phenytoin**: 15-20 mg/kg load, 100 mg TID or 300 mg daily, levels 10-20
- **Status epilepticus**: Refractory, super-refractory, propofol/pentobarbital coma
- **EEG findings**: Electrographic seizures, slowing, interictal discharges

**Extraction Priority**: CRITICAL (immediate management implications)

---

### 8. üéØ Brain Metastases ‚≠ê NEW
**Key Extractions**:
- **Primary cancer**: Lung (NSCLC/SCLC), breast, melanoma, renal (RCC), colon
- **Number of mets**: Single, oligometastatic, multiple
- **Procedures**: Craniotomy for resection (GTR/STR), SRS (Gamma Knife/CyberKnife), WBRT
- **Workup**: **CT CAP** (chest/abdomen/pelvis) - ESSENTIAL
- **Complications**: Wound dehiscence, infection, postop deficit

**Critical Terms**:
- **CT CAP** / **CT C/A/P**: Systemic staging (always needed)
- **SRS**: Stereotactic radiosurgery (Gamma Knife, CyberKnife)
- **WBRT**: Whole brain radiation therapy
- **GPA**: Graded Prognostic Assessment (0-4 score)
- **Wound dehiscence**: Incision breakdown, reclosure needed
- **Unknown primary**: Occult primary, needs PET scan

---

## üö® CRITICAL Extraction Targets (95%+ Accuracy Required)

1. **Ictus Date** (SAH): Legal, timeline critical
2. **Anticoagulation Status**: ALL hemorrhagic cases (cSDH, TBI, SAH)
   - Aspirin, Plavix, warfarin, Eliquis, Xarelto, Pradaxa
3. **Seizure Detection**: Immediate management needed
4. **Primary Cancer** (Metastases): Dictates treatment
5. **Grading Scales**: H&H, WFNS, Fisher, GCS

---

## üíä Medication Quick Reference

### Anticoagulants (CRITICAL)
- **Aspirin** (ASA, acetylsalicylic acid)
- **Clopidogrel** (Plavix)
- **Warfarin** (Coumadin)
- **Apixaban** (Eliquis)
- **Rivaroxaban** (Xarelto)
- **Dabigatran** (Pradaxa)
- **Ticagrelor** (Brilinta)

### Antiepileptics (AEDs)
- **Levetiracetam** (Keppra, LEV): Load 1000-1500 mg, Maint 500-1500 mg BID
- **Lacosamide** (Vimpat, LCM): Load 200-400 mg, Maint 100-200 mg BID
- **Phenytoin** (Dilantin, PHT): Load 15-20 mg/kg, Maint 100 mg TID, Levels 10-20
- **Fosphenytoin**: Load in PE (phenytoin equivalents)
- **Phenobarbital** (PHB): For refractory status
- **Lorazepam** (Ativan): First-line for acute seizure
- **Midazolam** (Versed): Drip for status
- **Propofol**: Refractory status epilepticus

### Steroids
- **Dexamethasone** (Decadron, dex): For vasogenic edema (tumors, mets)
- **Prednisone**: For endocrine insufficiency (CSF leak)
- **Hydrocortisone**: Stress dose steroids

### Vasospasm Management (SAH)
- **Norepinephrine** (Levophed)
- **Milrinone**

---

## üî¨ Imaging & Tests

### Imaging
- **CT head**: Hemorrhage, hydrocephalus, mass effect
- **CTA**: CT angiography (aneurysm, vasospasm)
- **MRI brain**: Tumor, metastases, ischemia
- **DSA**: Digital subtraction angiography (gold standard for aneurysm)
- **MRA**: MR angiography
- **TCD**: Transcranial Doppler (vasospasm)
- **CT CAP**: CT chest/abdomen/pelvis (metastases workup - ESSENTIAL)
- **PET scan**: Unknown primary cancer

### Tests
- **EEG**: Continuous (cEEG) for seizure monitoring
- **Beta-2 transferrin**: CSF leak confirmation
- **CSF analysis**: Protein, glucose, cell count, culture
- **Drug levels**: Phenytoin (10-20), phenobarbital

---

## üìã Grading Scales

### SAH
- **Hunt & Hess (H&H)**: I-V (clinical grade)
- **WFNS**: I-V (World Federation scale)
- **Fisher**: 1-4 (hemorrhage amount)
- **Modified Fisher (mFisher)**: 0-4 (IVH presence)

### TBI
- **GCS** (Glasgow Coma Scale): 3-15 (3=worst, 15=best)

### Motor Strength
- **MRC Grading**: 0-5
  - 0: No movement
  - 1: Flicker
  - 2: Movement without gravity
  - 3: Movement against gravity
  - 4: Movement against resistance
  - 5: Normal strength

### Metastases
- **GPA** (Graded Prognostic Assessment): 0-4 (higher=better)
  - Age, KPS, number of mets, extracranial disease

### Functional Status (ONLY GENERATIVE FIELD)
- **KPS**: Karnofsky Performance Status (0-100)
- **ECOG**: 0-5
- **mRS**: Modified Rankin Scale (0-6)

---

## üè• Discharge Destinations

1. **Home**: Independent, no services needed
2. **Home hospital** / **Repatriation**: Transfer to another institution
3. **Hospice**: Palliative care, end-of-life
4. **Satellite care**: Specialized post-acute facility
5. **Rehabilitation** / **Rehab**: Intensive therapy
6. **Long-term care (LTC)**: Extended nursing facility
7. **Palliative care**: Symptom management
8. **Death** / **Deceased** / **Expired**: Mortality

---

## üéØ Extraction Priority Levels

### CRITICAL (95%+ Accuracy)
- Ictus date, anticoagulation, seizures, primary cancer, grading scales

### HIGH (90%+ Accuracy)
- Motor exams, procedures, shunt settings, AED regimen, CT CAP

### MEDIUM (85%+ Accuracy)
- Complications, procedure levels, MMA embo, EEG findings, wound issues

---

## üìä Performance Targets

| Component | Baseline | With LLM | With ML | Target |
|-----------|----------|----------|---------|--------|
| Demographics | 95% | 98% | 99% | 99% |
| Procedures | 85% | 92% | 94% | 95% |
| Complications | 80% | 90% | 92% | 95% |
| Medications | 88% | 94% | 96% | 98% |
| **Overall** | **87%** | **92%** | **94%** | **95%** |

---

## üîÑ ML Learning Features

1. **Correction Tracking**: Every edit improves future extractions
2. **Summary Import**: Learn from completed discharge summaries
3. **Reverse Engineering**: Map notes ‚Üí summary transformations
4. **Pattern Confidence**: 0.70-0.95 based on match type
5. **Knowledge Base**: IndexedDB persistence, unlimited patterns
6. **PHI Anonymization**: 100% local, HIPAA-compliant
7. **Pathology-Specific**: Specialized learning per category

---

## üìÅ Documentation Structure

```
/Users/ramihatoum/Desktop/app/DCS/
‚îú‚îÄ‚îÄ PATHOLOGY_PATTERNS.md    (v2.0 - 1,200+ lines)
‚îÇ   ‚îî‚îÄ‚îÄ 8 pathologies, 200+ patterns
‚îú‚îÄ‚îÄ CLINICAL_OBJECTIVES.md   (Clinical constraints)
‚îú‚îÄ‚îÄ UPDATES_LOG.md           (Change tracking)
‚îú‚îÄ‚îÄ QUICK_REFERENCE.md       (This file)
‚îî‚îÄ‚îÄ untitled:Untitled-1      (Main architecture)
```

---

## üöÄ Implementation Checklist

- [ ] Integrate patterns into `extraction.js`
- [ ] Build pathology auto-detection
- [ ] Implement confidence scoring
- [ ] Create pattern priority queue
- [ ] Build learning feedback UI
- [ ] Test with sample notes (each pathology)
- [ ] Measure accuracy vs baseline
- [ ] Deploy ML learning engine
- [ ] Enable correction tracking
- [ ] Build summary import feature
- [ ] **Implement follow-up template system**
- [ ] **Build follow-up customization UI**

---

## üìã Follow-Up Templates Quick Reference

### Pathology-Specific Templates (All Fully Customizable)

#### 1. **Brain Tumors / Metastases**
- Surgeon: 4 weeks (wound check, pathology review)
- Oncology: 2-4 weeks after pathology (adjuvant therapy)
- MRI: 72 hrs post-op or 2-4 weeks (baseline)
- Suture removal: 14 days
- Dex taper: Over 2-4 weeks

#### 2. **Chronic Subdural Hematoma**
- Surgeon: 4 weeks with CT head
- CT outpatient: 4 weeks (assess reaccumulation)
- Anticoagulation restart: Per thrombosis (typically 2-4 weeks)

#### 3. **Subarachnoid Hemorrhage**
- NP: 2 weeks
- Interventionalist: 2-3 months with MRA
- Long-term MRA: Annual if stable

#### 4. **Transsphenoidal / Pituitary**
- Surgeon: 4 weeks
- ENT: 2 weeks (nasal inspection)
- Endocrinology: 6 weeks
- Bloodwork: 2 weeks (morning cortisol, ACTH, thyroid panel)

#### 5. **Spine Surgery**
- Surgeon: 2-4 weeks
- X-ray: 6 weeks (standing if fusion)
- PT: Start 2-6 weeks, duration 6-12 weeks
- Restrictions: No BLT for 6 weeks

#### 6. **Hydrocephalus (Shunt)**
- Surgeon: 4 weeks with CT head
- Shunt series: If concern for malfunction
- Education: Signs of malfunction, valve card

### Consultant Follow-Up Integration

#### Infectious Disease
- Antibiotics: Duration per ID recommendations
- Cultures: Repeat per ID if indicated
- PICC line: Care instructions, removal after course
- Typical durations:
  - Abscess: 4-6 weeks IV
  - Ventriculitis: 2-3 weeks IV
  - Meningitis: 2-3 weeks IV
  - Osteomyelitis: 6 weeks IV

#### Thrombosis Service
- Anticoagulation restart: 2-4 weeks (hemorrhagic procedures)
- Bridge therapy: If high-risk
- Monitoring: INR if warfarin, anti-Xa if LMWH
- Follow-up: Thrombosis clinic

#### Endocrinology
- Hormone replacement: Per bloodwork results
- Bloodwork timing: 2 weeks, 6 weeks, 3 months
- Stress dose steroids: If adrenal insufficiency
- Medical alert bracelet: Critical

### Medication Tapers

#### Dexamethasone (Standard)
- 4 mg BID √ó 3 days
- 3 mg BID √ó 3 days
- 2 mg BID √ó 3 days
- 2 mg daily √ó 3 days
- 1 mg daily √ó 3 days
- Discontinue

#### Antiepileptics
- Continue until neurology follow-up
- Duration: 3-6 months minimum if seizure occurred
- Level monitoring: If phenytoin/phenobarbital
- No levels needed: Levetiracetam

### Key Features
‚úÖ Auto-populated from case details
‚úÖ 100% customizable by clinician
‚úÖ **Must be reviewed before export**
‚úÖ ML learns from modifications
‚úÖ Consultant plans integrated
‚úÖ Medication tapers included
‚úÖ Procedure-specific instructions

---

**Version**: 2.1 (Added Follow-Up Templates)
**Last Updated**: October 13, 2025
**Status**: Ready for Implementation
**Coverage**: 8 pathologies, 200+ patterns, 500+ abbreviations, 6 follow-up templates
